UniProt ID | STEA3_HUMAN | |
---|---|---|
UniProt AC | Q658P3 | |
Protein Name | Metalloreductase STEAP3 | |
Gene Name | STEAP3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 488 | |
Subcellular Localization |
Endosome membrane Multi-pass membrane protein. Localizes to vesicular-like structures at the plasma membrane and around the nucleus. |
|
Protein Description | Endosomal ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Participates in erythroid iron homeostasis by reducing Fe(3+) to Fe(2+). Can also reduce of Cu(2+) to Cu(1+), suggesting that it participates in copper homeostasis. Uses NADP(+) as acceptor. May play a role downstream of p53/TP53 to interface apoptosis and cell cycle progression. Indirectly involved in exosome secretion by facilitating the secretion of proteins such as TCTP.. | |
Protein Sequence | MPEEMDKPLISLHLVDSDSSLAKVPDEAPKVGILGSGDFARSLATRLVGSGFKVVVGSRNPKRTARLFPSAAQVTFQEEAVSSPEVIFVAVFREHYSSLCSLSDQLAGKILVDVSNPTEQEHLQHRESNAEYLASLFPTCTVVKAFNVISAWTLQAGPRDGNRQVPICGDQPEAKRAVSEMALAMGFMPVDMGSLASAWEVEAMPLRLLPAWKVPTLLALGLFVCFYAYNFVRDVLQPYVQESQNKFFKLPVSVVNTTLPCVAYVLLSLVYLPGVLAAALQLRRGTKYQRFPDWLDHWLQHRKQIGLLSFFCAALHALYSFCLPLRRAHRYDLVNLAVKQVLANKSHLWVEEEVWRMEIYLSLGVLALGTLSLLAVTSLPSIANSLNWREFSFVQSSLGFVALVLSTLHTLTYGWTRAFEESRYKFYLPPTFTLTLLVPCVVILAKALFLLPCISRRLARIRRGWERESTIKFTLPTDHALAEKTSHV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Ubiquitination | -MPEEMDKPLISLHL -CCHHHCCCEEEEEE | 40.17 | - | |
11 | Phosphorylation | EMDKPLISLHLVDSD HHCCCEEEEEEECCC | 19.88 | 28450419 | |
17 | Phosphorylation | ISLHLVDSDSSLAKV EEEEEECCCCCCCCC | 31.73 | 25159151 | |
17 (in isoform 2) | Ubiquitination | - | 31.73 | - | |
19 | Phosphorylation | LHLVDSDSSLAKVPD EEEECCCCCCCCCCC | 31.07 | 25159151 | |
20 | Phosphorylation | HLVDSDSSLAKVPDE EEECCCCCCCCCCCC | 37.02 | 25159151 | |
23 | Ubiquitination | DSDSSLAKVPDEAPK CCCCCCCCCCCCCCC | 60.64 | - | |
27 (in isoform 2) | Phosphorylation | - | 61.88 | 27251275 | |
29 (in isoform 2) | Phosphorylation | - | 29.80 | 27251275 | |
30 (in isoform 2) | Phosphorylation | - | 61.21 | 27251275 | |
30 | Ubiquitination | KVPDEAPKVGILGSG CCCCCCCCCEEECCH | 61.21 | - | |
33 (in isoform 2) | Ubiquitination | - | 4.39 | - | |
42 | Phosphorylation | GSGDFARSLATRLVG CCHHHHHHHHHHHHC | 20.94 | 21406692 | |
45 | Phosphorylation | DFARSLATRLVGSGF HHHHHHHHHHHCCCC | 29.81 | 21406692 | |
97 | Phosphorylation | AVFREHYSSLCSLSD EHHHHHHHHHHHHHH | 20.81 | 23898821 | |
98 | Phosphorylation | VFREHYSSLCSLSDQ HHHHHHHHHHHHHHH | 26.65 | 24275569 | |
141 | Phosphorylation | ASLFPTCTVVKAFNV HHHCCCCHHHHHHCE | 30.71 | - | |
227 | Phosphorylation | LGLFVCFYAYNFVRD HHHHHHHHHHHHHHH | 11.75 | 18083107 | |
239 | Phosphorylation | VRDVLQPYVQESQNK HHHHHHHHHHHHCCC | 11.21 | 20068231 | |
243 | Phosphorylation | LQPYVQESQNKFFKL HHHHHHHHCCCCCCC | 23.20 | 20068231 | |
253 | Phosphorylation | KFFKLPVSVVNTTLP CCCCCCHHHHCCHHH | 20.57 | 20068231 | |
256 | N-linked_Glycosylation | KLPVSVVNTTLPCVA CCCHHHHCCHHHHHH | 25.78 | 22624035 | |
288 | Phosphorylation | QLRRGTKYQRFPDWL HHHCCCCCHHCCHHH | 12.54 | - | |
331 | Phosphorylation | PLRRAHRYDLVNLAV HHHHHHHHHHHHHHH | 12.08 | 18083107 | |
339 (in isoform 4) | Ubiquitination | - | 29.14 | 21890473 | |
339 (in isoform 3) | Ubiquitination | - | 29.14 | 21890473 | |
339 (in isoform 1) | Ubiquitination | - | 29.14 | 21890473 | |
339 | Ubiquitination | DLVNLAVKQVLANKS HHHHHHHHHHHCCCC | 29.14 | 21890473 | |
344 | N-linked_Glycosylation | AVKQVLANKSHLWVE HHHHHHCCCCCEEEE | 42.05 | 22624035 | |
349 (in isoform 2) | Ubiquitination | - | 7.05 | 21890473 | |
453 | S-palmitoylation | KALFLLPCISRRLAR HHHHHHHHHHHHHHH | 4.44 | 29575903 | |
469 | Phosphorylation | RRGWERESTIKFTLP HCCCCCCCEEEEECC | 41.47 | 30266825 | |
470 | Phosphorylation | RGWERESTIKFTLPT CCCCCCCEEEEECCC | 24.35 | 30266825 | |
471 (in isoform 3) | Ubiquitination | - | 4.87 | 21890473 | |
472 | Ubiquitination | WERESTIKFTLPTDH CCCCCEEEEECCCCH | 32.17 | 2189047 | |
472 (in isoform 1) | Ubiquitination | - | 32.17 | 21890473 | |
474 | Phosphorylation | RESTIKFTLPTDHAL CCCEEEEECCCCHHH | 27.16 | 26699800 | |
477 | Phosphorylation | TIKFTLPTDHALAEK EEEEECCCCHHHHHH | 43.46 | 30108239 | |
479 (in isoform 2) | Phosphorylation | - | 25.72 | 24719451 | |
482 (in isoform 2) | Ubiquitination | - | 19.61 | 21890473 | |
483 (in isoform 3) | Ubiquitination | - | 58.69 | 21890473 | |
484 | Ubiquitination | TDHALAEKTSHV--- CCHHHHHHCCCC--- | 50.12 | 21139048 | |
484 (in isoform 1) | Ubiquitination | - | 50.12 | 21890473 | |
485 | Phosphorylation | DHALAEKTSHV---- CHHHHHHCCCC---- | 18.64 | 30266825 | |
486 | Phosphorylation | HALAEKTSHV----- HHHHHHCCCC----- | 33.06 | 30266825 | |
487 (in isoform 2) | Phosphorylation | - | 34.24 | 27251275 | |
494 (in isoform 2) | Ubiquitination | - | 21890473 | ||
495 (in isoform 2) | Phosphorylation | - | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of STEA3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of STEA3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STEA3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
BNI3L_HUMAN | BNIP3L | physical | 12606722 | |
PMYT1_HUMAN | PKMYT1 | physical | 12606722 | |
TT21A_HUMAN | TTC21A | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
615234 | Anemia, hypochromic microcytic, with iron overload 2 (AHMIO2) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...